Cargando…
Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection
Acute asthma remains one of the most frequent causes of children's access to healthcare. Asthma exacerbation is an essential defining characteristic of its severity, and respiratory infections entail increased risks of exacerbations with potential hospitalization. In the literature, contradicto...
Autores principales: | Paladini, Erika, Giovannini, Mattia, Barni, Simona, Liccioli, Giulia, Sarti, Lucrezia, Novembre, Elio, Mori, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685498/ https://www.ncbi.nlm.nih.gov/pubmed/34938694 http://dx.doi.org/10.3389/fped.2021.675281 |
Ejemplares similares
-
Acute FPIES and DIES: is a G lacking?
por: Novembre, Elio, et al.
Publicado: (2023) -
Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease
por: Barni, Simona, et al.
Publicado: (2021) -
Immunoglobulin E (IgE)-Mediated Food Allergy in Children: Epidemiology, Pathogenesis, Diagnosis, Prevention, and Management
por: Barni, Simona, et al.
Publicado: (2020) -
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
por: Giovannini, Mattia, et al.
Publicado: (2019) -
Venom immunotherapy protocols in the pediatric population: how to choose?
por: Saretta, Francesca, et al.
Publicado: (2023)